
Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …

David Meek has been appointed to the newly created position of chief commercial officer at the biotechnology firm Endocyte. Meek …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

